TY  - JOUR
AU  - Lozano, Maria L
AU  - Mingot-Castellano, Maria E
AU  - Perera, María M
AU  - Jarque, Isidro
AU  - Campos-Alvarez, Rosa M
AU  - González-López, Tomás J
AU  - Carreño-Tarragona, Gonzalo
AU  - Bermejo, Nuria
AU  - Lopez-Fernandez, Maria F
AU  - de Andrés, Aurora
AU  - Valcarcel, David
AU  - Casado-Montero, Luis F
AU  - Alvarez-Roman, Maria T
AU  - Orts, María I
AU  - Novelli, Silvana
AU  - González-Porras, Jose R
AU  - Bolaños, Estefanía
AU  - López-Ansoar, Elsa
AU  - Orna-Montero, Elisa
AU  - Vicente, Vicente
PY  - 2020
DO  - 10.1016/j.bcmd.2020.102505
UR  - http://hdl.handle.net/10668/16322
T2  - Blood cells, molecules & diseases
AB  - Ten years after their availability, thrombopoietin receptor agonists (TPO-RA) have heralded a paradigm shift in the treatment of immune thrombocytopenia (ITP). This study was aimed to analyze the implementation of current recommendations in the...
LA  - en
KW  - Elderly
KW  - Guidelines
KW  - ITP
KW  - TPO-RA
KW  - Adult
KW  - Age Factors
KW  - Aged
KW  - Aged, 80 and over
KW  - Disease Management
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Purpura, Thrombocytopenic, Idiopathic
KW  - Receptors, Thrombopoietin
KW  - Retrospective Studies
KW  - Treatment Outcome
KW  - Young Adult
TI  - A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients.
TY  - research article
VL  - 86
ER  -